Evidence map›Paper›PMID 40189697›Full record

ArticleNPJ precision oncology2025

The single-cell spatial landscape of stage III colorectal cancers.

Andrew Su, HoJoon Lee, Minh Tran, Richard C Dela Cruz, Anuja Sathe, Xiangqi Bai, Ignacio Wichmann, Lance Pflieger, Bryce Moulton, Tyler Barker and 6 more

Abstract read
In one paragraph

Article in NPJ precision oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Spatium: A Protein Language Foundation Model for Spatial Proteomics.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Terminally exhausted CD8Frontiers in immunology · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Andrew Su *Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, 94305, USA.
HoJoon Lee *Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Minh Tran *Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, 4072, Australia.
Richard C Dela CruzIntermountain Healthcare, Saint George, UT, 84770, USA.
Anuja SatheDivision of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Xiangqi BaiDivision of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Ignacio WichmannDivision of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Lance PfliegerIntermountain Healthcare, Saint George, UT, 84770, USA.
Bryce MoultonIntermountain Healthcare, Saint George, UT, 84770, USA.
Tyler BarkerIntermountain Healthcare, Saint George, UT, 84770, USA.
Derrick HaslemIntermountain Healthcare, Saint George, UT, 84770, USA.
David JonesIntermountain Healthcare, Saint George, UT, 84770, USA.
Lincoln NadauldIntermountain Healthcare, Saint George, UT, 84770, USA.
Quan NguyenInstitute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, 4072, Australia. quan.nguyen@uq.edu.au.
Hanlee P JiDivision of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, 94305, USA. genomics_ji@stanford.edu.
Terence RhodesIntermountain Healthcare, Saint George, UT, 84770, USA.

Funding

Project 3: Molecular Risk Stratification of Gastric Precancerous LesionsP01CA265772 · NCI · STANFORD UNIVERSITY · PI Hanlee P Ji · 2023 to 2026
$9.0M
Integrating cancer genomics and spatial architecture of tumor infiltrating lymphocytesR01CA280089 · NCI · STANFORD UNIVERSITY · PI Hanlee P Ji · 2023 to 2026
$1.9M
Fullbright Fullbright ScholarshipNational Health and Medical Research Council 2001514National Health and Medical Research Council Investigator Grant, Australia GNT2008928NCI NIH HHS P01 CA265772NCI NIH HHS R01 CA280089NIH HHS 5P01CA265772NIH HHS 5R01CA280089
6 · The paper itself

Abstract

We conducted a spatial analysis of stage III colorectal adenocarcinomas using Hyperion Imaging Mass Cytometry, examining 52 tumors to assess the tumor microenvironment at the single-cell level. This approach identified 10 distinct cell phenotypes in the tumor microenvironment, including stromal and immune cells, with a subset showing a proliferative phenotype. By focusing on spatial neighborhood interactions and tissue niches, particularly regions with tumor-infiltrating lymphocytes, we investigated how cellular organization relates to clinicopathological and molecular features such as microsatellite instability (MSI) and recurrence. We determined that microsatellite stable (MSS) colorectal cancers had an increased risk of recurrence if they had the following features: 1) a low level of stromal tumor-infiltrating lymphocytes, and 2) low interactions between CD4 + T cells and stromal cells. Our results point to the utility of spatial single-cell interaction analysis in defining novel features of the tumor immune microenvironments and providing useful clinical cell-related spatial biomarkers.

Identifiers

PMID40189697
PMCPMC11973205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.